Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles The Journal of Pediatrics Year : 2020

Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation

Stéphane Ducassou
  • Function : Author
Helder Fernandes
Yves Bertrand
  • Function : Author
Wadih Abou Chahla
  • Function : Author
Marlène Pasquet
Guy Leverger
  • Function : Author
Vincent Barlogis
Caroline Thomas
Sophie Bayart
  • Function : Author
Isabelle Pellier
  • Function : Author
Corinne Armari-Alla
  • Function : Author
Corinne Guitton
  • Function : Author
Nathalie Cheikh
Djamel Kherfellah
  • Function : Author
Gilles Vassal
Salim Laghouati
  • Function : Author
Nathalie Aladjidi
  • Function : Author
No file

Dates and versions

hal-03142779 , version 1 (16-02-2021)

Identifiers

Cite

Stéphane Ducassou, Helder Fernandes, Hélène Savel, Yves Bertrand, Thierry Leblanc, et al.. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. The Journal of Pediatrics, 2020, ⟨10.1016/j.jpeds.2020.12.018⟩. ⟨hal-03142779⟩

Collections

U1219
39 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More